DeepMed Research

UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1943-01-01

Employees: 8.1K

Market Cap: -

Website: http://www.utsouthwestern.edu

Clinical Trials

Transplantation of Tissue Cultured Human Amniotic Epithelial Cells Onto Damaged Ocular Surfaces

Not Applicable

Withdrawn

Conditions: Corneal Epithelial Dystrophy

First Posted Date: 2006-06-27

Last Posted Date: 2018-08-22

Lead Sponsor: University of Texas Southwestern Medical Center

Registration Number: NCT00344708

Locations: 🇺🇸
Aston Ambulatory Care Center, Dallas, Texas, United States
🇺🇸
University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States

Study to Improve Scientific Understanding of the Cardiovascular Actions of Cocaine

Phase 1

Withdrawn

Conditions: Cocaine Induced Sympathoexciation and Vasoconstriction

First Posted Date: 2006-06-20

Last Posted Date: 2019-01-16

Lead Sponsor: University of Texas Southwestern Medical Center

Registration Number: NCT00338546

Locations: 🇺🇸
Univ of Texas Southwestern Medical Center, Dallas, Texas, United States

Determining Optimal Continuation Treatment Duration for Depressed Children and Adolescents

Not Applicable

Completed

Conditions: Depression

First Posted Date: 2006-06-02

Last Posted Date: 2014-01-08

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 200

Registration Number: NCT00332787

Locations: 🇺🇸
Children's Medical Center at Dallas, Outpatient Psychiatry Clinic, Dallas, Texas, United States

Safety and Efficacy of Cellcept and Avonex as Combination Treatment in Multiple Sclerosis

Phase 2

Completed

Conditions: Multiple Sclerosis

Interventions: Drug: Mycophenolate Mofetil (CellCept)

First Posted Date: 2006-05-11

Last Posted Date: 2013-06-19

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 43

Registration Number: NCT00324506

Locations: 🇺🇸
Buffalo Neuroimaging Analysis Center (BNAC), Buffalo, New York, United States
🇺🇸
Michigan Institute for Neurological Disorders (M.I.N.D.), Farmington Hills, Michigan, United States
🇺🇸
University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States

RFT-5-dgA in Patients With Metastatic Melanoma

Phase 2

Completed

Conditions: Metastatic Melanoma

First Posted Date: 2006-04-12

Last Posted Date: 2019-11-12

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 41

Registration Number: NCT00314093

Locations: 🇺🇸
National Cancer Institute (NCI), Bethesda, Maryland, United States

Comparison Study of High Frequency Percussive Ventilation With Conventional Ventilation

Phase 2

Withdrawn

Conditions: Pneumonia
Respiratory Distress Syndrome, Adult
Mechanical Ventilation

First Posted Date: 2006-03-28

Last Posted Date: 2019-01-17

Lead Sponsor: University of Texas Southwestern Medical Center

Registration Number: NCT00308022

Locations: 🇺🇸
Parkland Health and Hospital System, Dallas, Texas, United States

Use of Beta Blockers in Elderly Trauma Patients

Phase 2

Conditions: Multiple Trauma
Cardiovascular Diseases
Aged

First Posted Date: 2006-03-14

Last Posted Date: 2007-05-10

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 148

Registration Number: NCT00302692

Locations: 🇺🇸
Parkland Memorial Hospital, Dallas, Texas, United States

Priapism in Boys and Men With Sickle Cell Disease - Demographics, Characteristics and Prevalence

Completed

Conditions: Priapism
Anemia, Sickle Cell

First Posted Date: 2006-03-08

Last Posted Date: 2019-02-01

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 1464

Registration Number: NCT00300235

Locations: 🇺🇸
Ohio State University, Columbus, Ohio, United States
🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸
Children's Hospital of Boston, Boston, Massachusetts, United States

and more 24 locations

Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma

Phase 2

Completed

Conditions: Mesothelioma

Interventions: Drug: bevacizumab
Drug: cisplatin
Drug: pemetrexed

First Posted Date: 2006-02-23

Last Posted Date: 2020-10-20

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 53

Registration Number: NCT00295503

Locations: 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States

Growth Hormone Use in Adolescents and Adults With Cystic Fibrosis

Not Applicable

Withdrawn

Conditions: Cystic Fibrosis

First Posted Date: 2006-02-06

Last Posted Date: 2019-03-12

Lead Sponsor: University of Texas Southwestern Medical Center

Registration Number: NCT00287430

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy